drugset / Trial / NCT02772588
AASUR in High Risk Prostate Cancer
Phase 2
Completed
64 enrolled
Memorial Sloan Kettering Cancer Center
Janssen Pharmaceuticals · collabUniversity of Michigan · collabWeill Medical College of Cornell University · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether anti-testosterone medications, when administered before, during, and after high-dose, precision radiation, will be effective in preventing the prostate cancer from returning.
Timeline
- Start
- 2016-05-12
- Primary completion
- 2026-01-22
- Completion
- 2026-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | — | — |
| Subject | Apalutamide | Small molecule | — | — |
| Subject | Leuprolide | Other / unclassified | — | — |